Skip to main content

Animations

MJFF Publications

2541 - 2550 of 6295 Results
Title
Year
  • Year
  • 2024
  • 2024
  • 2025
  • 2024
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • 2025
  • Summary Details
    OPEN
    Title: Proportion and distribution of neurotransmitter-defined cell types in the ventral tegmental area and substantia nigra pars compacta
    Journal Name: Addiction Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.addicn.2024.100183
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Structure and activation of the human autophagy-initiating ULK1C:PI3KC3-C1 supercomplex
    Journal Name: Biophysical Journal
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bpj.2023.11.2100
    Best OA location URL:
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Characterization of [3H]AZ12464237 as a high affinity, non-nucleotide antagonist radioligand for the P2Y12 receptor
    Journal Name: Biochemical Pharmacology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.bcp.2025.116900
    Citation Count: 1
  • Summary Details
    OPEN
    Title: A structural pathway for class III PI 3-kinase activation by the myristoylated GTP-binding pseudokinase VPS15
    Journal Name: Biophysical Journal
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.bpj.2023.11.384
    Best OA location URL:
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Modulatory effect of levodopa on the basal ganglia-cerebellum connectivity in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00954-9
    Citation Count: 0
  • Summary Details
    OPEN
    Title: The role of alpha-synuclein in synucleinopathy: Impact on lipid regulation at mitochondria–ER membranes
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00960-x
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Characterizing the expression profile of 3R tau pathology in Pick’s disease
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1126/sciadv.adt6105
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Data-driven characterization of distinct cognitive subtypes in Parkinson’s disease dementia
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41531-025-00970-9
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Predicting dementia in people with Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00983-4
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Differential memory enrichment of cytotoxic CD4 T cells in Parkinson’s disease patients reactive to α-synuclein
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00981-6
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.